Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Identification of threshold for large (dramatic) effects that would obviate randomized trials is not possible
Iztok Hozo, Benjamin Djulbegović, Austin J. Parish, John P A Ioannidis (2022). Identification of threshold for large (dramatic) effects that would obviate randomized trials is not possible. , 145, DOI: https://doi.org/10.1016/j.jclinepi.2022.01.016.
Article60 days agoFederal Funding and Citation Metrics of US Biomedical Researchers, 1996 to 2022
John P A Ioannidis, Iztok Hozo, Benjamin Djulbegović (2022). Federal Funding and Citation Metrics of US Biomedical Researchers, 1996 to 2022. , 5(12), DOI: https://doi.org/10.1001/jamanetworkopen.2022.45590.
Article60 days agoThere is no upper limit on the maximum effect that can be detected in randomized trials
Benjamin Djulbegović, Iztok Hozo, Renata Iskander, Austin J. Parish, Jonathan Kimmelman, John P A Ioannidis (2025). There is no upper limit on the maximum effect that can be detected in randomized trials. , 184, DOI: https://doi.org/10.1016/j.jclinepi.2025.111828.
Article60 days agoFederal Funding and Citation Metrics of Biomedical Research in the USA
John P A Ioannidis, Iztok Hozo, Benjamin Djulbegović (2022). Federal Funding and Citation Metrics of Biomedical Research in the USA. , DOI: https://doi.org/10.1101/2022.08.31.22279467.
Preprint60 days agoStudy Design and the Drug Development Process—Reply
John P A Ioannidis, Iztok Hozo, Benjamin Djulbegović (2014). Study Design and the Drug Development Process—Reply. , 311(19), DOI: https://doi.org/10.1001/jama.2014.3829.
Letter60 days ago